FERBER & CO. GmbH
Phone: +49 89 41 95 16–0 | Contact: Manfred C. Ferber · Alexander von Hachenburg | info@ferberco.com
www.ferberco.com
Industry Focus
Healthcare, pharma, digital / technology, consumer, retail, industrials, B2B services
Transaction size
€ 25 m – € 500 m
Reference Deals
Selected Transactions: (1) Sale of OTOWAXOL German earwax removal OTC brand from Cooper Consumer Health SAS to InfectoPharm Arzneimittel und Consilium GmbH. (2) Sale of the pharmacy brand portfolio consisting of “DermaSel”, “Murnauer’s Bachblüten” as well as the CBD gels “Cannaren” and “Cannaxil” of Murnauer Markenvertrieb GmbH to Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung. (3) Sale of a majority stake of FR L’Osteria SE to McWin Partners. (4) Acquisition of Arkopharma SE by Dermapharm from Montagu Private Equity LLP. (5) Merger of Vitafy Brands and EVP Group. (6) Acquisition of C3-Cannabinoid Compound Company GmbH by Dermapharm from Canopy Growth Corporation. (7) Sale of a majority ownership stake in Dermazentrum in an Owners Buy-out to Halder. (8) USD 40m private placement of Wellster Healthtech.
Profile
FERBER & CO., founded in 1988, is a leading investment banking house focusing on M&A as well as Corporate Finance for medium-sized transactions ranging from € 25 million to € 500 million, as well as customized M&A advice from entrepreneurs to entrepreneurs. FERBER & CO. contributes to the success of its customers through its independence, entrepreneurial commitment, sector focus and internationality.
Services
(1) Divestitures and acquisitions, (2) Management buy-outs (MBOs), Management buy-ins (MBIs) and leveraged buy-outs (LBOs), (3) Mergers and joint ventures, (4) Public to Private/ Public take-overs, (5) Private placements/ Corporate Finance.